Related Experiment Video
Updated: May 28, 2026
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Carbohydrate-functionalized chitosan fiber for influenza virus capture
Xuebing Li1, Peixing Wu, George F Gao
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. lixb@im.ac.cn
Biomacromolecules
|October 8, 2011
Summary
Researchers developed novel chitosan-based materials incorporating sialyllactose (SL) to combat influenza virus. These materials effectively inhibit viral attachment and remove the virus, offering a promising strategy for infection control.
Area of Science:
- Biomaterials Science
- Virology
- Polymer Chemistry
Background:
- Influenza virus's high transmissibility and genetic variability pose challenges for control.
- The hemagglutinin (HA) protein on the virus surface binds to host cell glycoligands, making it a key target for antiviral strategies.
Purpose of the Study:
- To develop and evaluate novel sialyllactose (SL)-incorporated chitosan-based materials for inhibiting influenza virus adhesion and decontamination.
- To explore the potential of these materials as antiviral agents and for broader biomedical applications.
Main Methods:
- Synthesized water-soluble SL-chitosan conjugate and SL-functionalized chitosan fiber.
- Grafted lactoside with an aldehyde-functionalized aglycone to chitosan amino groups.
- Enzymatically sialylated the modified chitosan using sialyltransferase.
Main Results:
- The water-soluble SL-chitosan conjugate demonstrated high affinity binding to HA and effectively inhibited viral attachment to erythrocytes.
- The SL-functionalized chitosan fiber efficiently removed influenza virus from aqueous solutions.
- The developed materials show potential as virus adsorbents for influenza prevention and control.
Conclusions:
- SL-incorporated chitosan materials are effective in inhibiting influenza virus adhesion and decontamination.
- These materials offer a versatile platform for biofunctionalization, with potential applications beyond antiviral designs, including diagnostics and drug delivery.
